Neuropathic Pain Management

NCT01263132 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

104

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetic Neuropathies
Polyneuropathies

Interventions

DRUG: F0434
DRUG: Gabapentin

Sponsor

Merck KGaA, Darmstadt, Germany

Collaborators

[object Object]